Celadon Pharmaceuticals PLC (CEL) — Financial Flexibility Index
Celadon Pharmaceuticals PLC (CEL) has a Financial Flexibility Index of -0.21x as of June 2024. Free cash flow of GBX-1.26 Million (operating CF GBX-1.29 Million minus capex GBX29.50K) represents 0% of total liabilities (GBX6.01 Million). Also explore Celadon Pharmaceuticals PLC (CEL) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celadon Pharmaceuticals PLC Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Celadon Pharmaceuticals PLC across 5 annual periods. Check strategic asset allocation of Celadon Pharmaceuticals PLC to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Celadon Pharmaceuticals PLC (2019–2023)
Year-by-year free cash flow to debt coverage for Celadon Pharmaceuticals PLC. For the full company profile including market capitalisation, see Celadon Pharmaceuticals PLC market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.93x | GBX-5.63 Million | GBX-5.97 Million | GBX6.04 Million | ▼ -44.3% |
| 2022 | -0.65x | GBX-4.01 Million | GBX-6.10 Million | GBX6.21 Million | ▲ +95.1% |
| 2021 | -13.21x | GBX-2.61 Million | GBX-3.15 Million | GBX197.23K | ▼ -7960.8% |
| 2020 | 0.17x | GBX630.67K | GBX-77.57K | GBX3.75 Million | ▲ +21979.9% |
| 2019 | 0.00x | GBX1.98K | GBX1.98K | GBX2.60 Million | — |